Performance and Safety of a New Medical Device (Polybactum) for Reducing the Recurrence Rate of Bacterial Vaginosis: Protocol for a Multicenter, Open-Label, Noncontrolled International Clinical Trial (POLARIS Study)

BACKGROUND: The medical literature has reported that recurrent bacterial vaginosis (RBV) has a relapse rate of 35% within 3 months and 60% within 12 months after antibiotic administration. Products that are able to provide a barrier effect against the biofilm produced by Gardnerella vaginalis could...

Descripción completa

Detalles Bibliográficos
Autores principales: Murina, Filippo, Inghirami, Paolo, Biriș, Marius, Sîrbu, Daniela, Barattini, Dionisio Franco, Sbrocca, Federica, Ardolino, Luca Ivan, Mangrella, Mario, Casolati, Elena, Roșu, Serban, Crișan, Ciprian Doru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401192/
https://www.ncbi.nlm.nih.gov/pubmed/37471117
http://dx.doi.org/10.2196/42787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401192/
https://www.ncbi.nlm.nih.gov/pubmed/37471117
http://dx.doi.org/10.2196/42787

Ejemplares similares